Prolonged electrocerebral silent barbiturate coma in intractable seizure disorders

Epilepsia. 1988 Jan-Feb;29(1):63-6. doi: 10.1111/j.1528-1157.1988.tb05100.x.

Abstract

Barbiturate coma (BC) is a known modality for terminating resistant convulsive status epilepticus. It is usually applied until seizure activity ends. We recently adopted a modified protocol of prolonged, electrocerebral silent BC to treat patients with chronic seizure activity resistant to multiple regimens of antiepileptic drugs. Four patients, aged 4 months to 10 years, with long-standing intractable generalized seizures were treated. Seizure frequency ranged from one to two to numerous times per day. Following BC, one patient has been seizure free during 8 months of follow-up, and another has had only two seizures in 18 months. A 4-month-old infant was seizure-free for 2 weeks after BC and then died from underlying CNS disease. A 10-year-old girl died during BC from shock and hyperpyrexia. The results obtained in our patients indicate that prolonged electrocerebral silent BC may exert a beneficial long-term effect in treatment of intractable seizure disorders. This procedure might also be beneficial in other forms of epilepsy.

Publication types

  • Case Reports

MeSH terms

  • Child
  • Child, Preschool
  • Chronic Disease
  • Coma*
  • Electroencephalography
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Infusions, Intravenous
  • Injections, Intravenous
  • Male
  • Methods
  • Seizures / physiopathology
  • Seizures / therapy*
  • Thiopental / administration & dosage*
  • Time Factors

Substances

  • Thiopental